132 related articles for article (PubMed ID: 32899425)
1. Impact of Albumin and Omeprazole on Steady-State Population Pharmacokinetics of Voriconazole and Development of a Voriconazole Dosing Optimization Model in Thai Patients with Hematologic Diseases.
Khan-Asa B; Punyawudho B; Singkham N; Chaivichacharn P; Karoopongse E; Montakantikul P; Chayakulkeeree M
Antibiotics (Basel); 2020 Sep; 9(9):. PubMed ID: 32899425
[TBL] [Abstract][Full Text] [Related]
2. Model-based Voriconazole Dose Optimization in Chinese Adult Patients With Hematologic Malignancies.
Liu Y; Qiu T; Liu Y; Wang J; Hu K; Bao F; Zhang C
Clin Ther; 2019 Jun; 41(6):1151-1163. PubMed ID: 31079860
[TBL] [Abstract][Full Text] [Related]
3. Identification of factors influencing the pharmacokinetics of voriconazole and the optimization of dosage regimens based on Monte Carlo simulation in patients with invasive fungal infections.
Wang T; Chen S; Sun J; Cai J; Cheng X; Dong H; Wang X; Xing J; Dong W; Yao H; Dong Y
J Antimicrob Chemother; 2014 Feb; 69(2):463-70. PubMed ID: 24084636
[TBL] [Abstract][Full Text] [Related]
4. Population Pharmacokinetics of Voriconazole in Patients With Invasive Aspergillosis: Serum Albumin Level as a Novel Marker for Clearance and Dosage Optimization.
Chantharit P; Tantasawat M; Kasai H; Tanigawara Y
Ther Drug Monit; 2020 Dec; 42(6):872-879. PubMed ID: 32947557
[TBL] [Abstract][Full Text] [Related]
5. Population Pharmacokinetics of Voriconazole and Dose Optimization in Elderly Chinese Patients.
Wang J; Shen Y; Wu Z; Ge W
J Clin Pharmacol; 2024 Feb; 64(2):253-263. PubMed ID: 37766506
[TBL] [Abstract][Full Text] [Related]
6. Population Pharmacokinetics of Voriconazole and Optimization of Dosage Regimens Based on Monte Carlo Simulation in Patients With Liver Cirrhosis.
Ren QX; Li XG; Mu JS; Bi JF; Du CH; Wang YH; Zhu H; Lv P; Zhao QG
J Pharm Sci; 2019 Dec; 108(12):3923-3931. PubMed ID: 31562869
[TBL] [Abstract][Full Text] [Related]
7. Dosage optimization of voriconazole in children with haematological malignancies based on population pharmacokinetics.
Wu Y; Lv C; Wu D; Qi J; Cai R; Zhou S; Li C; Wei Y; Liu T
J Clin Pharm Ther; 2022 Dec; 47(12):2245-2254. PubMed ID: 36345158
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of voriconazole and initial dosage optimization in patients with talaromycosis.
Jiang Z; Wei Y; Huang W; Li B; Zhou S; Liao L; Li T; Liang T; Yu X; Li X; Zhou C; Cao C; Liu T
Front Pharmacol; 2022; 13():982981. PubMed ID: 36225581
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics, safety and dosing optimization of voriconazole in patients with liver dysfunction: A prospective observational study.
Tang D; Yan M; Song BL; Zhao YC; Xiao YW; Wang F; Liang W; Zhang BK; Chen XJ; Zou JJ; Tian Y; Wang WL; Jiang YF; Gong GZ; Zhang M; Xiang DX
Br J Clin Pharmacol; 2021 Apr; 87(4):1890-1902. PubMed ID: 33010043
[TBL] [Abstract][Full Text] [Related]
10. Effect of proton pump inhibitor on plasma voriconazole concentration in Thai patients.
Chayakulkeeree M; Poovipirom N; Siengwattana P; Maneerattanaporn M
J Med Assoc Thai; 2015 Mar; 98(3):232-7. PubMed ID: 25920292
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic Modeling of Voriconazole To Develop an Alternative Dosing Regimen in Children.
Gastine S; Lehrnbecher T; Müller C; Farowski F; Bader P; Ullmann-Moskovits J; Cornely OA; Groll AH; Hempel G
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038273
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics and covariate-based dosing individualization of voriconazole in lung transplant recipients.
Dvorackova E; Sima M; Vyskocilova K; Kotowski T; Dunovská K; Klapkova E; Havlin J; Lischke R; Slanar O
J Chemother; 2024 Feb; 36(1):35-44. PubMed ID: 37272077
[TBL] [Abstract][Full Text] [Related]
13. Application of Population Pharmacokinetic Analysis to Characterize CYP2C19 Mediated Metabolic Mechanism of Voriconazole and Support Dose Optimization.
Li S; Wu S; Gong W; Cao P; Chen X; Liu W; Xiang L; Wang Y; Huang J
Front Pharmacol; 2021; 12():730826. PubMed ID: 35046798
[No Abstract] [Full Text] [Related]
14. PHARMACOKINETICS OF ORALLY ADMINISTERED VORICONAZOLE IN AFRICAN PENGUINS (SPHENISCUS DEMERSUS) AFTER SINGLE AND MULTIPLE DOSES.
Hyatt MW; Wiederhold NP; Hope WW; Stott KE
J Zoo Wildl Med; 2017 Jun; 48(2):352-362. PubMed ID: 28749255
[TBL] [Abstract][Full Text] [Related]
15. Effect of omeprazole on the steady-state pharmacokinetics of voriconazole.
Wood N; Tan K; Purkins L; Layton G; Hamlin J; Kleinermans D; Nichols D
Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):56-61. PubMed ID: 14616415
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics of tacrolimus in Thai kidney transplant patients: comparison with similar data from other populations.
Vadcharavivad S; Praisuwan S; Techawathanawanna N; Treyaprasert W; Avihingsanon Y
J Clin Pharm Ther; 2016 Jun; 41(3):310-28. PubMed ID: 27191538
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients.
Hennig S; Wainwright CE; Bell SC; Miller H; Friberg LE; Charles BG
Clin Pharmacokinet; 2006; 45(11):1099-114. PubMed ID: 17048974
[TBL] [Abstract][Full Text] [Related]
18. Model-Oriented Dose Optimization of Voriconazole in Critically Ill Children.
Wang J; Xu H; Li R; Wu S; Zou J; Wang Y
Antimicrob Agents Chemother; 2021 Aug; 65(9):e0049321. PubMed ID: 34152812
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic/pharmacodynamic analysis of voriconazole against Candida spp. and Aspergillus spp. in children, adolescents and adults by Monte Carlo simulation.
Xu G; Zhu L; Ge T; Liao S; Li N; Qi F
Int J Antimicrob Agents; 2016 Jun; 47(6):439-45. PubMed ID: 27179818
[TBL] [Abstract][Full Text] [Related]
20. Application of different pharmacokinetic models to describe and predict pharmacokinetics of voriconazole in magellanic penguins following oral administration.
Parsley RA; Mutlow AG; Hansted J; Taverne FJ; Tell LA; Gehring R
J Vet Pharmacol Ther; 2019 Jan; 42(1):74-84. PubMed ID: 30175535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
